|Laparoscopic partial nephrectomy for multilocular cystic renal cell carcinoma ...|
To report on the perioperative outcomes of laparoscopic partial nephrectomy (LPN) for multilocular cystic renal cell carcinoma (MCRCC) and evaluate the feasibility of this minimally invasive technique as a potential gold standard treatment for MCRCC.
7thSpace Interactive (press release) - Tue, 22 Apr 2014 17:22
|Intrinsic Imaging Awarded Global Clinical Trial for Hepatocellular Carcinomas|
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver. According to the American Cancer Society, Hepatocellular carcinoma has become one of the most common types of cancer in many countries with more than 700,000 people diagnosed ...
PR Web (press release) - Tue, 22 Apr 2014 23:56
|Research and Markets: Global Metastatic Renal Cell Carcinoma Therapeutics ...|
This report provides comprehensive information on the therapeutic development for Metastatic Renal Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...
Business Wire (press release) - Tue, 22 Apr 2014 02:56
|Improving early detection of oral squamous cell carcinoma with advanced ...|
The PeriRx salivary biomarker test for oral cancer is scheduled to launch in the late spring/early summer and will provide dental professionals with the most clinically validated test available to assist in the early detection of oral squamous cell ...
Dentistry IQ - Thu, 17 Apr 2014 15:18
|First reported case of tumor hypoglycemia from recurrent renal cell carcinoma|
A case of non–islet cell tumor hypoglycemia caused by recurrent renal cell carcinoma as a result of the production of high-molecular-weight insulinlike growth factor–2 was reported online in the Journal of Clinical Oncology. Malignant fibrous ...
The Oncology Report - Thu, 17 Apr 2014 08:52
|Vismodegib effective in basal cell carcinoma|
NEW YORK — The hedgehog inhibitor vismodegib demonstrated encouraging activity in patients with basal cell carcinoma, according to results of a single-center study presented at the HemOnc Today Melanoma and Cutaneous Malignancies meeting.
Healio - Sat, 12 Apr 2014 09:07
|Therapy with vismodegib effective in locally advanced, metastatic basal cell ...|
NEW YORK — In this video, Rogerio I. Neves, MD, PhD, FACS, presents data from a single-center study in which the hedgehog inhibitor, vismodegib, demonstrated encouraging activity in patients with basal cell carcinoma. Vismodegib (Erivedge, Genentech) ...
Healio - Sat, 12 Apr 2014 22:03
|Leukemoid reaction in sarcomatoid renal cell carcinoma: a two-case report|
Leukemoid reaction is a sign for poor prognosis in solid tumors so is sarcomatoid renal cell carcinoma (SRCC) when compared to more differentiated histologies. Here, we are reporting two cases of leukemoid reaction after radical nephrectomy, both of ...
7thSpace Interactive (press release) - Sat, 19 Apr 2014 07:48